Intelligence Platform
Patents
Browse 2,639 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6746662
pH sensitive MRI contrast agents
expired patentUS 6743936
Composites made using functionalized nanoparticles
expired patentUS 6740751
Methods and compositions for stabilizing microtubules and intermediate filaments in striat
expired patentUS 6740320
Recombinant P53 adenovirus methods and compositions
expired patentUS 6740744
VMP-like sequences of pathogenic borrelia
expired patentUS 6737059
Methods of inhibiting inflammatory processes and alleviating symptoms associated with mult
expired patentUS 6737052
Induction of programmed cell death by N5 gene
expired patentUS 6730659
Antimicrobial peptides and methods of use thereof
expired patentUS 6730307
Anti-cryptosporidium parvum preparations
expired patentUS 6723548
DNA repair polypeptides and methods of use
expired patentUS 6723329
Use of parapox B2L protein to modify immune responses to administered antigens
expired patentUS 6723338
Compositions and methods for treating lymphoma
expired patentUS 6720180
Wounded epithelium-specific transcript
expired patentUS 6720344
Methods and compositions for stimulating osteoblast proliferation or treating malignant ce
expired patentUS 6719983
VMP-like sequences of pathogenic Borrelia
expired patentUS 6716877
Method to treat chronic heart failure and/or elevated cholesterol levels
expired patentUS 6709858
Hyperthermic inducible expression vectors for gene therapy and methods of use thereof
expired patentUS 6706691
Immunosupportive drug sparing diet
expired patentUS 6703414
Device and method for treating restenosis
expired patentUS 6703020
Antibody conjugate methods for selectively inhibiting VEGF
expired patentUS 6699459
Methods of treating lung inflammation
expired patentUS 6696585
Functionalized nanoparticles
expired patentUS 6696089
Nanogel networks including polyion polymer fragments and biological agent compositions the
expired patentUS 6696079
Delivery and activation through liposome incorporation of diaminocyclohexane platinum(II)
expired